SK22795A3 - Sulfonamidodioxepanes, method of their preparation, intermediates, salts and their using - Google Patents

Sulfonamidodioxepanes, method of their preparation, intermediates, salts and their using Download PDF

Info

Publication number: SK22795A3
Authority: SK; Slovakia
Prior art keywords: acceptable salts; pharmaceutically acceptable; formula; compounds; compound
Prior art date: 1994-02-21

Application number

SK227-95A

Other languages

English (en)

Slovak (sk)

Inventor

Miljenko Dumic

Darko Filic

Mladen Vinkovic

Blanka Jamnicky

Original Assignee

Pliva Pharm & Chem Works

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-21

Filing date

1995-02-20

Publication date

1995-09-13

1995-02-20 Application filed by Pliva Pharm & Chem Works filed Critical Pliva Pharm & Chem Works

1995-09-13 Publication of SK22795A3 publication Critical patent/SK22795A3/sk

Links

150000003839 salts Chemical class 0.000 title claims description 33
238000000034 method Methods 0.000 title claims description 16
238000002360 preparation method Methods 0.000 title claims description 6
239000000543 intermediate Substances 0.000 title claims description 3
150000001875 compounds Chemical class 0.000 claims description 45
150000007529 inorganic bases Chemical class 0.000 claims description 12
125000004432 carbon atom Chemical group C* 0.000 claims description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
125000000217 alkyl group Chemical group 0.000 claims description 8
229910052751 metal Inorganic materials 0.000 claims description 8
239000002184 metal Substances 0.000 claims description 8
239000003960 organic solvent Substances 0.000 claims description 7
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 6
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 5
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
239000011230 binding agent Substances 0.000 claims description 4
206010012601 diabetes mellitus Diseases 0.000 claims description 4
125000005843 halogen group Chemical group 0.000 claims description 4
229940124530 sulfonamide Drugs 0.000 claims description 4
150000003458 sulfonic acid derivatives Chemical class 0.000 claims description 4
125000002252 acyl group Chemical group 0.000 claims description 3
125000003545 alkoxy group Chemical group 0.000 claims description 3
239000000825 pharmaceutical preparation Substances 0.000 claims description 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
239000002904 solvent Substances 0.000 claims description 3
150000003456 sulfonamides Chemical class 0.000 claims description 3
125000004442 acylamino group Chemical group 0.000 claims description 2
125000001118 alkylidene group Chemical group 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims description 2
125000004663 dialkyl amino group Chemical group 0.000 claims description 2
229910052739 hydrogen Inorganic materials 0.000 claims description 2
239000001257 hydrogen Substances 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 claims description 2
229940126904 hypoglycaemic agent Drugs 0.000 claims description 2
150000007522 mineralic acids Chemical class 0.000 claims description 2
150000007524 organic acids Chemical class 0.000 claims description 2
125000005010 perfluoroalkyl group Chemical group 0.000 claims description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 2
238000003786 synthesis reaction Methods 0.000 claims description 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
239000004480 active ingredient Substances 0.000 claims 1
239000003472 antidiabetic agent Substances 0.000 claims 1
239000003814 drug Substances 0.000 claims 1
150000002918 oxazolines Chemical class 0.000 claims 1
239000007858 starting material Substances 0.000 abstract description 6
230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
ZHKJHQBOAJQXQR-UHFFFAOYSA-N 1H-azirine Chemical compound N1C=C1 ZHKJHQBOAJQXQR-UHFFFAOYSA-N 0.000 abstract description 3
XYYAFYBVUUMOTF-UHFFFAOYSA-N 3,5,8-trioxabicyclo[5.1.0]octane Chemical compound C1OCOCC2OC21 XYYAFYBVUUMOTF-UHFFFAOYSA-N 0.000 abstract description 2
HTJXZCZFMUOOFW-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-[1,3]dioxepino[5,6-d][1,3]oxazole Chemical compound C1OCOC=C2OCNC21 HTJXZCZFMUOOFW-UHFFFAOYSA-N 0.000 abstract 1
AGNSCOWWQUDEGE-UHFFFAOYSA-N 6-amino-1,3-dioxepan-5-ol Chemical compound NC1COCOCC1O AGNSCOWWQUDEGE-UHFFFAOYSA-N 0.000 abstract 1
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
239000000203 mixture Substances 0.000 description 14
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
-1 p-substituted phenyl group Chemical group 0.000 description 11
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
239000000741 silica gel Substances 0.000 description 6
229910002027 silica gel Inorganic materials 0.000 description 6
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 4
UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 4
238000001704 evaporation Methods 0.000 description 4
230000008020 evaporation Effects 0.000 description 4
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
150000001340 alkali metals Chemical class 0.000 description 3
150000001408 amides Chemical class 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
150000008280 chlorinated hydrocarbons Chemical class 0.000 description 3
150000002170 ethers Chemical class 0.000 description 3
239000008103 glucose Substances 0.000 description 3
GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
WERWVEUXZQOGMO-CHWSQXEVSA-N n-[4-[[(5r,6s)-6-hydroxy-1,3-dioxepan-5-yl]sulfamoyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)N[C@H]1[C@H](O)COCOC1 WERWVEUXZQOGMO-CHWSQXEVSA-N 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
150000003462 sulfoxides Chemical class 0.000 description 3
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
150000008044 alkali metal hydroxides Chemical class 0.000 description 2
239000002585 base Substances 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
150000004649 carbonic acid derivatives Chemical class 0.000 description 2
150000001733 carboxylic acid esters Chemical class 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
150000002576 ketones Chemical class 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
KERKSHQWMCWPBT-UHFFFAOYSA-N n-phenylacetamide;sulfurochloridic acid Chemical compound OS(Cl)(=O)=O.CC(=O)NC1=CC=CC=C1 KERKSHQWMCWPBT-UHFFFAOYSA-N 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
239000011591 potassium Substances 0.000 description 2
238000010992 reflux Methods 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 2
229960001052 streptozocin Drugs 0.000 description 2
HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 2
150000003457 sulfones Chemical class 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
239000008096 xylene Substances 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
AGNSCOWWQUDEGE-RFZPGFLSSA-N (5s,6r)-6-amino-1,3-dioxepan-5-ol Chemical compound N[C@@H]1COCOC[C@H]1O AGNSCOWWQUDEGE-RFZPGFLSSA-N 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
DGBCMXNLXXITDO-UHFFFAOYSA-N 2,2-dimethyl-1,3-dioxepan-5-ol Chemical compound CC1(C)OCCC(O)CO1 DGBCMXNLXXITDO-UHFFFAOYSA-N 0.000 description 1
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
YOYAIZYFCNQIRF-UHFFFAOYSA-N 2,6-dichlorobenzonitrile Chemical compound ClC1=CC=CC(Cl)=C1C#N YOYAIZYFCNQIRF-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
GRDXCFKBQWDAJH-UHFFFAOYSA-N 4-acetamidobenzenesulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C=C1 GRDXCFKBQWDAJH-UHFFFAOYSA-N 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
238000006136 alcoholysis reaction Methods 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
229910000272 alkali metal oxide Inorganic materials 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
238000005915 ammonolysis reaction Methods 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
229940043430 calcium compound Drugs 0.000 description 1
150000001674 calcium compounds Chemical class 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
239000002775 capsule Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000006704 dehydrohalogenation reaction Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000006735 epoxidation reaction Methods 0.000 description 1
150000002118 epoxides Chemical class 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
230000003345 hyperglycaemic effect Effects 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
229910001867 inorganic solvent Inorganic materials 0.000 description 1
239000003049 inorganic solvent Substances 0.000 description 1
125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
PKOFBDHYTMYVGJ-UHFFFAOYSA-N n-(4-sulfamoylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(S(N)(=O)=O)C=C1 PKOFBDHYTMYVGJ-UHFFFAOYSA-N 0.000 description 1
QBFCOEVCOIWCLB-UHFFFAOYSA-N n-(6-chloro-1,3-dioxepan-5-yl)acetamide Chemical class CC(=O)NC1COCOCC1Cl QBFCOEVCOIWCLB-UHFFFAOYSA-N 0.000 description 1
QNBJIEPSMNZNJU-ZIAGYGMSSA-N n-[4-[[(5r,6s)-6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl]sulfamoyl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)N[C@H]1[C@H](O)COC(C)(C)OC1 QNBJIEPSMNZNJU-ZIAGYGMSSA-N 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
150000002916 oxazoles Chemical class 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
239000006187 pill Substances 0.000 description 1
150000003112 potassium compounds Chemical class 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000006277 sulfonation reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Epoxy Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

SK227-95A 1994-02-21 1995-02-20 Sulfonamidodioxepanes, method of their preparation, intermediates, salts and their using SK22795A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR941124		1994-02-21

Publications (1)

Publication Number	Publication Date
SK22795A3 true SK22795A3 (en)	1995-09-13

Family

ID=10946196

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK227-95A SK22795A3 (en)	1994-02-21	1995-02-20	Sulfonamidodioxepanes, method of their preparation, intermediates, salts and their using

Country Status (8)

Country	Link
EP (1)	EP0668274B1 (cs)
AT (1)	ATE170183T1 (cs)
CZ (1)	CZ44295A3 (cs)
DE (1)	DE69504220T2 (cs)
ES (1)	ES2123167T3 (cs)
HU (1)	HUT72498A (cs)
PL (1)	PL307385A1 (cs)
SK (1)	SK22795A3 (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962704A (en) *	1995-09-26	1999-10-05	Japan Tobacco Inc.	Production of amide derivatives and intermediate compounds therefor
DK0984000T3 (da) *	1995-09-26	2009-04-06	Japan Tobacco Inc	Fremgangsmåde til fremstilling af amidderivater og intermediatforbindelser

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4001655A1 (de) *	1990-01-18	1991-07-25	Schering Ag	6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

1995
- 1995-02-20 AT AT95102353T patent/ATE170183T1/de not_active IP Right Cessation
- 1995-02-20 EP EP95102353A patent/EP0668274B1/en not_active Expired - Lifetime
- 1995-02-20 SK SK227-95A patent/SK22795A3/sk unknown
- 1995-02-20 CZ CZ95442A patent/CZ44295A3/cs unknown
- 1995-02-20 ES ES95102353T patent/ES2123167T3/es not_active Expired - Lifetime
- 1995-02-20 HU HU9500506A patent/HUT72498A/hu unknown
- 1995-02-20 DE DE69504220T patent/DE69504220T2/de not_active Expired - Fee Related
- 1995-02-20 PL PL95307385A patent/PL307385A1/xx unknown

Also Published As

Publication number	Publication date
DE69504220D1 (de)	1998-10-01
ES2123167T3 (es)	1999-01-01
DE69504220T2 (de)	1999-04-29
EP0668274B1 (en)	1998-08-26
PL307385A1 (en)	1995-09-04
HUT72498A (en)	1996-05-28
ATE170183T1 (de)	1998-09-15
EP0668274A1 (en)	1995-08-23
CZ44295A3 (en)	1995-10-18
HU9500506D0 (en)	1995-04-28

Publication	Publication Date	Title
EP0984934B1 (en)	2003-01-08	Novel orally active iron (iii) chelators
CH653021A5 (fr)	1985-12-13	Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
EP0243018B1 (en)	1990-10-24	Thiolactam-n-acetic acid derivatives, their production and use
FR2645152A1 (fr)	1990-10-05	3h-pteridinones-4, procedes de preparation et medicaments les contenant
FI93013C (fi)	1995-02-10	Menetelmä terapeuttisesti käyttökelpoisten pyridopyridatsinonijohdannaisten valmistamiseksi
EP0160618B1 (en)	1991-08-14	Hydantoin derivatives and pharmaceutical compositions containing them
PL145196B1 (en)	1988-08-31	Method of obtaining novel 2-ketoindolo-1-carbonamides
Sakamoto et al.	1985	Studies on prodrugs. IV. Preparation and characterization of N-(5-substituted 2-oxo-1, 3-dioxol-4-yl) methyl norfloxacin
US4258033A (en)	1981-03-24	2,6-Diaminonebularines
SK22795A3 (en)	1995-09-13	Sulfonamidodioxepanes, method of their preparation, intermediates, salts and their using
US5635529A (en)	1997-06-03	Sulfonamidodioxepanes, methods of preparation, intermediates, salts and use thereof
WO1990010624A1 (en)	1990-09-20	Pyrimidine type mevalonolactones
EP0093945B1 (en)	1988-11-23	1,4-dihydropyridine derivatives
RUBAT et al.	1988	Synthesis and analgesic effect of N-substituted 5-arylidene-6-methyl-3-(4H)-pyridazinones
EP0184801B1 (en)	1990-09-26	Chromene derivative, process for preparing the same and antiallergic agent containing the same
US3535319A (en)	1970-10-20	Pyrimidinyl or pyrazinoyl-4-imino-dihydropyridine compounds and process
CA1209142A (fr)	1986-08-05	Procede d'obtention de nouvelles cyanoguanidines et des compositions pharmaceutiques en renfermant
US4663319A (en)	1987-05-05	3-(1,3-dithiol-2-ylidene)-2,4-dioxopyrrolidines, -piperidines, and -hexahydroazepines and use thereof against hepatic diseases
Bicking et al.	1965	Behavioral Stimulants. 4-Oxazolidinones
US4034045A (en)	1977-07-05	2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes
CS221844B2 (en)	1983-04-29	Method of making the 5-substituted dialuric acids
JPH072776A (ja)	1995-01-06	アンジオテンシンｉｉ拮抗性ピリジン誘導体
US4097609A (en)	1978-06-27	2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes
FR2545488A1 (fr)	1984-11-09	Nouveaux carbamates cycliques a chaine laterale du type arylmethyle ou aryloxymethyle, leurs procedes de preparation et leur application en therapeutique
DK154075B (da)	1988-10-10	Analogifremgangsmaade til fremstilling af 4-carbamoyl-5-hydroxy-imidazolderivater eller farmaceutisk acceptable salte deraf